Showing results (341-350 of 1,234) with videos related to
Sort By:
Pageof 124
Cancer Treatment and Research Communications|October 22, 2020
Study the relationship of endothelial damage / dysfunction due to occupational exposure to low dose ionizing radiation versus high dose exposure during radiotherapySanaa A El-Benhawy, Nadia A Sadek, Mahmoud M Kamel, et al.Cancer Treatment and Research Communications|November 8, 2020
Nutritional outcomes in head and neck cancer patients: is intensive nutritional care worth it?Sheilla de Oliveira Faria, Doris Howell, Marco Auré Vamondes Kulcsar, et al.Cancer Treatment and Research Communications|February 3, 2020
Latest advances in management of small cell lung cancer and other neuroendocrine tumors of the lungHussein A Assi, Sukhmani K PaddaCancer Treatment and Research Communications|November 27, 2020
Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistanceYaron Ilan, Zachary SpigelmanCancer Treatment and Research Communications|December 3, 2020
Advances in the management of non-small cell lung cancer (NSCLC): A new practice changing data from asco 2020 annual meetingMohammed Sqalli Houssaini, Meriem Damou, Nabil IsmailiCancer Treatment and Research Communications|January 6, 2022
Pregnancy induced hyperplasia of residual breast tissue following risk reducing contralateral mastectomy - simply interesting or a clinically important observationOmali Pitiyarachchi, Kelly-Anne Phillips, Michael FriedlanderCancer Treatment and Research Communications|March 16, 2021
Safe and effective use of nivolumab plus ipilimumab in a patient with metastatic clear-cell renal cell carcinoma with sarcomatoid dedifferentiation and end stage renal disease on hemodialysisLeah K Shaw, Andrew J Wiele, Kanishka Sircar, et al.Cancer Treatment and Research Communications|November 19, 2021
Invited commentary on "Neoadjuvant pertuzumab plus trastuzumab in combination with anthracycline-free chemotherapy regimen in patients with HER2 positive breast cancer: Real-world data from a single center in India"Co MichaelCancer Treatment and Research Communications|November 27, 2021
Laboratory biomarkers of an effective antitumor immune response. Clinical significanceA M Malkova, V V Sharoyko, N V Zhukova, et al.Cancer Treatment and Research Communications|March 23, 2021
The prevalence of asymptomatic COVID-19 infection in cancer patients. A cross-sectional study at a tertiary cancer center in New York CityMudathir Ibrahim, Vijaya Natarajan, Pooja Murthy, et al.Pageof 124